Application Nr Approved Date Route Status External Links
NDA022145 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Adult Patients : Isentress And Isentress Hd Are Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors (Hiv-1 Insti) Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adult Patients ( 1 ). Pediatric Patients: Isentress Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Pediatric Patients Weighing At Least 2 Kg ( 1 ). Isentress Hd Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Pediatric Patients Weighing At Least 40 Kg ( 1 ). Adult Patients : Isentress® And Isentress® Hd Are Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adult Patients. Pediatric Patients: Isentress Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Pediatric Patients Weighing At Least 2 Kg. Isentress Hd Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Pediatric Patients Weighing At Least 40 Kg.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Raltegravir Potassium RALTEGRAVIR POTASSIUM ZINC13831130

Comments